ADTX Q3 2025 Earnings Deep Losses and Lack of Revenue Continue as Stock Tumbles Over 45 ALXO Q1 2026 Earnings NarrowerthanExpected Loss per Share Mirrors ClinicalStage Focus APYX Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise But Stock Declines BiomX Inc PHGE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline FRME Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline RELX Q2 2025 Earnings Modest EPS Beat Reflects Steady Underlying Performance